Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;57 Suppl 2(Suppl 2):214-221.
doi: 10.1111/1475-6773.13992. Epub 2022 May 2.

The diabetes health plan and medication adherence among individuals with low incomes

Kimberly Danae Cauley Narain  1   2   3 , Norman Turk  1 , O Kenrik Duru  1 , Tannaz Moin  1   4 , Sam Ho  5 , Carol M Mangione  1   6
Affiliations

The diabetes health plan and medication adherence among individuals with low incomes

Kimberly Danae Cauley Narain et al. Health Serv Res. 2022 Dec.

Abstract

Objective: To test the impact of the Diabetes Health Plan (DHP), a diabetes-specific insurance plan that lowers out-of-pocket costs for diabetes-related medications and clinical visits, on adherence to oral hypoglycemic medications among low-income adults with Type 2 Diabetes (T2DM).

Data sources and study setting: Cohort of adults (18-64) with T2DM, an annual household income <USD 30,000, and who were continuously enrolled in an employer-sponsored UnitedHealthcare plan for at least two years between 2009 and 2014.

Study design: We employed a linear regression Difference-In-Differences (DID) approach with a matched comparison group. To assess for differential DHP effects across adherent versus non-adherent patients, we ran a Difference-in-Difference-in-Differences (DDD) analysis by including an interaction term that included indicators for DHP exposure status and time, and low versus high baseline medication adherence.

Data collection: The analytic data set is limited to employer groups that purchased the DHP and standard benefit plans from UnitedHealthcare, had internal pharmacy contracts; complete pharmacy claims data, and sufficient medical claims and lab data to identify employees and their dependents with T2DM.

Principal findings: Our DID analysis did not show improved medication adherence associated with employer DHP adoption. However, the DDD model suggested a difference between DHP-exposed and comparison beneficiaries when comparing the relative effect on individuals who were adherent versus non-adherent at baseline, as suggested by the significant three-way interaction term (10.2,p = 0.028). This effect was driven by the 8.2 percentage point increase in medication adherence for the DHP subsample that was non-adherent at baseline.

Conclusions: The DHP may benefit low-income patients with low baseline medication adherence. Value-based insurance design may be an important strategy for mitigating income disparities in T2DM outcomes.

Keywords: diabetes; health disparities; health equity; low-income; medication non-adherence; value based insurance design.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Sample size flow chart
See this image and copyright information in PMC

References

    1. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA. 2015;314(10):1021‐1029. - PubMed
    1. Saydah S, Lochner K. Socioeconomic status and risk of diabetes‐related mortality in the U.S. Public Health Rep. 2010;125(3):377‐388. - PMC - PubMed
    1. Miller GE, Sarpong EM, Hill SC. Does increased adherence to medications change health care financial burdens for adults with diabetes? J Diabetes. 2015;7(6):872‐880. - PubMed
    1. Lo‐Ciganic WH, Donohue JM, Jones BL, et al. Trajectories of diabetes medication adherence and hospitalization risk: a retrospective cohort study in a large state Medicaid program. J Gen Intern Med. 2016;31(9):1052‐1060. - PMC - PubMed
    1. Vojta D, De Sa J, Prospect T, Stevens S. Effective interventions for stemming the growing crisis of diabetes and prediabetes: a national payer's perspective. Health Aff (Millwood). 2012;31(1):20‐26. - PubMed

Publication types

Substances